---
title: "Whole Genome Sequencing (WGS) Long Read Equipment & Consumables"
ocid: "ocds-h6vhtk-029bf5"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029bf5"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-029bf5.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-029bf5.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "GENOMICS ENGLAND"
published: "2021-03-15"
---

# Whole Genome Sequencing (WGS) Long Read Equipment & Consumables

Buyer: GENOMICS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-029bf5

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029bf5)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-029bf5.json)

## Summary

The procurement process is being led by Genomics England, focusing on the acquisition of "Whole Genome Sequencing (WGS) Long Read Equipment & Consumables". This project falls under the health technology industry category and is located in Hinxton, Cambridge, UK. The procurement method utilised is a limited tender, negotiated without the publication of a contract notice. The contract, valued at £2,000,000, was signed on 15th March 2021, and represents a unique engagement with Oxford Nanopore Technologies Limited due to their exclusive technology that meets specific requirements for this large-scale project.

This tender presents significant business growth opportunities, particularly for companies that specialise in laboratory reagents and medical consumables. Suppliers with expertise in genomic sequencing technology and related medical devices may find themselves well-suited to participate in future procurement activities. Given the unique nature of this project and the established partnership with Oxford Nanopore Technologies, it highlights the potential for innovation and collaboration within the health technology sector, particularly for those focused on cancer research and clinical applications.

## Notice

A large-scale Long Read Whole Genome Sequencing (WGS) project using Oxford Nanopore Technologies long read technology in order to evaluate its potential for clinical use in cancer.

### Lot Information

Lot 1

Genomics England has a Spending Review (SR) objective involving a large-scale long read whole genome sequencing (WGS) project. In order to deliver this long read WGS project Genomics England have engaged and are proposing to partner with Oxford Nanopore Technologies Limited (ONT) to maximise its long read technology at scale to evaluate its potential for clinical use in cancer. This project requires sequencing at scale of around 2,000 germline:tumour pairs over the next 12 month period. A beneficial commercial agreement that represents the unique nature of the engagement in terms of technological development and value has been agreed between the parties to deliver the scope of this project in its entirety. ONT occupy a unique position in the sequencing market globally in terms of read length and throughput technology that makes this project viable. The primary sequencing instrument within this project is the Promethion P48 consuming Flowcell reagents and other associated consumables. A combination of these attributes will deliver the scaling required for the project and the commercial agreement between the parties ensures successful sequencing objectives for clinical use in cancer, within the 12 month SR period.

### Procurement Information

The Contracting Authority (i) has a legal personality; (ii) is mainly funded by the Department of Health and Social Care; and (iii) has been established for the specific purpose of meeting needs in the general interest and does not have an industrial or commercial character and therefore meets the definition of a "body governed by public law" under the Public Contracts Regulations 2015 ("PCR"). The PCR covers "public contracts" which means contracts for pecuniary interest which have as their object the execution of works, the supply of products or the provision of services. The Contract is a goods or services contract under PCR, therefore, caught by the PCR and bound to follow public procurement rules. Regulation 32(2)(b)(ii) PCR describes the single operator exclusion and is the premise for this award without prior publication. This specific exclusion relates to a demonstration that only Oxford Nanopore Technologies Limited could deliver the goods and services described for technical reasons and reasons of scalability, where the goods and services cannot be obtained from any other economic operator to sufficiently meet the volume throughput of long read whole genome sequencing. The scope of requirements in this notice are the basis for this assessment. For technical reasons, it has been determined that Oxford Nanopore Technologies Limited are the only provider able to meet the justified requirements set out. Furthermore, they are also the only organisation able to deliver the requirement at the scale specified. Further details are provided within this notice and should be read in conjunction with this explanation. The Contracting Authority will enter into a contract with Oxford Nanopore Technologies Limited following the conclusion of a minimum 10-day standstill period from the date of issue of this notice. The 10-day standstill period will end on Thursday 25th March 2021 at 11.59pm GMT, enabling a contract to be signed on Friday 26th March 2021.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/005252-2021 |
| Notice type | Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Negotiated without publication of a contract notice |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 15 Mar 2021 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 Mar 2021 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £2,000,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Not specified |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | GENOMICS ENGLAND |
| Locality | LONDON |
| Post town | Central London |
| Postcode | EC1M 6BQ |
| Country | England |
| ITL 1 | TLI London |
| ITL 2 | TLI4 Inner London - East |
| ITL 3 | TLI43 Haringey and Islington |
| Local authority | Islington |
| Electoral ward | Bunhill |
| Westminster constituency | Islington South and Finsbury |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | OXFORD NANOPORE TECHNOLOGIES |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products
- 38 - Laboratory, optical and precision equipments (excl. glasses)

### Codes

- 33140000 - Medical consumables
- 33190000 - Miscellaneous medical devices and products
- 33696200 - Blood-testing reagents
- 33696500 - Laboratory reagents
- 38000000 - Laboratory, optical and precision equipments (excl. glasses)

## Release History

- 15 Mar 2021 at 22:56 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/005252-2021

## Notice URLs

- http://www.genomicsengland.co.uk

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-029bf5. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-029bf5.json.